HTGM News and Press, HTG Molecular Diagnostics Inc. From 05/13/20

HTG Molecular (NASDAQ: HTGM ): Q1 GAAP EPS of -$0.08 beats by $0.02 . Revenue of $2.23M (-30.3% Y/Y) misses by $1.02M . Shares +1.2% . Press Release More news on: HTG Molecular Diagnostics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,

TUCSON, Ariz., May 13, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the first quarter ended March 31, 2020. “With the COVID-19 pandem...

TUCSON, Ariz., May 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the first quarter ended March 31, 2020 after the market close ...

HTG Molecular Diagnostics, Inc. (HTGM) Q4 2019 Earnings Conference Call March 25, 2020 16:30 ET Company Participants Monique Kosse - LifeSci Advisors John Lubniewski - President, CEO & Director Shaun McMeans - SVP, Finance & Administration, CFO, Secretary and Treasurer ...

These Penny Stocks Have Started Turning Heads; Are They On Your List? Well, here we are again. Another volatile week is in its second half and the market volatility rages on. The latest coronavirus stimulus deal has taken over headlines with markets expecting it to help the economy. While this...

HTG Molecular (NASDAQ: HTGM ): FY GAAP EPS of -$0.51 beats by $0.02 . Revenue of $19.2M (-10.7% Y/Y) in-line. Press Release More news on: HTG Molecular Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, ,

Increased product and product-related services revenue over prior year, benefitting from expanded menu of profiling assays and increased number of customers adopting technology Released new HTG EdgeSeq Reveal data analysis software (version 2.0.0) Call scheduled for today, Mar...

TUCSON, Ariz., March 17, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the year ended December 31, 2019 after the market close on W...

TUCSON, Ariz., Feb. 19, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that John Lubniewski, President and CEO, will present a corporate overview at the SVB Leerink 9 th ...

TUCSON, Ariz., Feb. 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today highlighted the HTG EdgeSeq Mouse mRNA Tumor Response Panel as a way to identify endogenous targets of cardia...